Focal Points with Brom Rector

Marcus Capone is founder of TARA Mind. TARA Mind is an employee benefit provider that allows companies of all sizes to offer Ketamine therapy to their employees as a mental health benefit.Marcus is also the Chairman and Co-Founder of VETS: Veterans Exploring Treatment Solutions, VETS is a non profit that provides resources, research, and advocacy for U.S. Special Operations veterans seeking alternative mental health treatments. Marcus is a Veteran Navy SEAL, Marcus retired from active duty in 2013, after several tours at SEAL Teams 10 and 6.More on TARA Mind: https://www.taramind.com/XEIA Venture Partners (Brom's VC fund) is an investor in TARA Mind: www.xeiavp.com

Amit Deshwar is the Founder & CTO of Kerna Labs. Backed by Gradient Ventures (Google's AI fund), Kerna Labs is building foundational AI models that aim to unlock the full potential of mRNA as the universal toolkit for genetic medicine. Kerna Labs' CSO is Melissa J. Moore, the former CSO of Moderna who helped lead the development of the Moderna COVID vaccine. Topics include: What is RNA What is an mRNA therapeutic The potential of mRNA therapeutics vs traditional drugs How AI fits into the design of mRNA therapies And more Kerna Labs; https://kernalabs.ai/ Amit Deshwar: https://x.com/amitdeshwar Brom Rector: https://x.com/therealbrom

Ramsay Brown, founder of Mission Control - a leading provider of AI agents / synthetic workers to the defense industry, joins us to discuss the end of the Anthropocene, what a world filled with synthetic labor looks like, Project Stargate, Trump and AI, why you need to be Rick Rubin and more. Learn more about Mission Control at https://usemissioncontrol.com/ Follow Rams on X: https://x.com/_ramsaybrown Follow Brom on X: https://x.com/therealbrom

Dillan DiNardo, the founder and CEO of Mindstate Design Labs, a drug development company using AI to enable the precision design of altered states of consciousness joins the podcast to discuss the state of psychedelics, AI, consciousness, why Marc Andreessen hates psychedelics, and the intersection of all these things. Follow Brom on Twitter: https://twitter.com/therealbrom Learn more about Mindstate: https://www.mindstate.design/ Brom is the founder of focalpoint partners: https://www.focalpointlp.com/

Today’s guests are MJ Antonini & Nicki Driscoll, the founders of NeuroBionics, a neurotech startup out of MIT. NeuroBionics is making Deep Brain Stimulation minimally invasive though the development of nano fibers that are 10X thinner than traditional Deep Brain Stimulation leads - allowing them to be inserted endovascularly into the brain. Check out NeuroBionics at https://neurobionics.io/

Can a succulent plant from South Africa treat premature ejaculation? John Boghossian and Dr Ryan Protzko from Kadence Bio think so. www.kadencebio.com

Can brain implants treat your depression? Ok, technically this would be a skull implant, not a brain implant - but still! Jacob Robinson from Motif Neurotech discusses the future of minimally invasive electronic medicine from mental health and beyond. This is a crossover episode from the Business Trip podcast.

Dr. Elliot Marseille, UC Berkeley Healthcare Economist, discusses the economic and financial aspects of psychedelic therapies. They explore the cost, insurance coverage, and value of a psychedelic experience. They also highlight the cost-effectiveness of MDMA therapy for PTSD and the potential future availability and affordability of psychedelic therapies.

🤖 ChatGPT & Dall-E today - misinformation, bias & worker displacement tomorrow. In a world where artificial intelligence is becoming increasingly advanced, it's more important than ever to ensure that AI systems are aligned with our values and behave in ways that are safe for humanity. But what exactly does it mean to align an AI system, and how do we go about ensuring its safety?    Here to answer these questions and more (including the most important question: will AIs take psychedelics?) is Ramsay Brown. Ramsay is the Founder of the AI Responsibility Lab (AIRL). AIRL builds venture-scale deep tech solutions for AI Safety and AI Resilience. AIRL's flagship product, Mission Control, integrates Responsible AI training, AI Risk Management, and AI Governance orchestration to drive fairness, explainability, and trust throughout the entire AI lifecycle.   Check out AIRL here: https://www.takecontrol.ai/   Ramsay on Twitter: https://twitter.com/_ramsaybrown  Brom on twitter: https://twitter.com/therealbrom 5:30 - What are the major concerns in AI safety?  10:30 - Examples of AI gone bad   16:00 - What is the hardest part of AI alignment?  21:00 - What is Ramsay’s unique angle on AI alignment?   24:00 - Is the world ready for conversations about responsible AI?    25:30 - Who is responsible for responsible AI?   32:00 - What regulations would Ramsay put into place?   41:00 - Eliezer Yudkowsky  47:00 - The era of synthetic labor  55:00 - The Turing Test is a red herring   1:04:00 - What jobs are safe from the AI takeover?   1:14:00 - Will machines do psychedelics?

Zach Haigney is the author of The Trip Report, a newsIetter that covers the emerging psychedelic science, medicine, and policy landscape.  In this conversation, Zach and Brom discuss emerging trends, questions and hot topics in the psychedelics industry including:   The lines of tension between Drug Development and Drug Policy Directive vs Non-Directive Psychedelic Therapy  How Psychedelics are inverting the traditional drug development model  What business models will emerge in psychedelics?  Are fears about VC investment in psychedelics overstated?   How psychedelics can be thought of as a form of hormetic therapy  What can psychedelics be used for outside of treating mental health issues?   We also discuss The Trip Report's recent acquisition by Beckley Waves.   You can check out The Trip Report here:  https://thetripreport.substack.com/  Follow Zach on Twitter: https://twitter.com/zach_haigney Follow Brom on Twitter:  https://twitter.com/therealbrom  Make sure to subscribe to the show!